Research Workshop • Novel Nutritional and Metabolic Status Biomarkers (RW-2025)

The 2025 Research Workshop – Novel Nutritional and Metabolic Status Biomarkers, will focus on the current evidence for biomarkers in use as well as those in development to capture nutritional and metabolic status, which is critical in medical care. There is strong evidence that adequate nutritional support remains a key component of favorable patient outcomes and could significantly modulate metabolic, biological, and pathological processes.

Historically, anthropometric and serological assessments have been utilized to assess nutritional and metabolic status. However, there is wide variability in their clinical and research utilization. In addition, despite the paucity of evidence-based support, many are used in clinical decision processes. Over the past decade, there has been burgeoning research into , transcriptomics, genomics, and metabolomics and their relevance to individual/personalized medicine as a tool for objective cross-sectional and longitudinal nutritional and metabolic status assessment and response to therapy. There is also a major interest in new technology focusing on activity trackers providing non-invasive and real-time assessment of body composition and calorie burn, as well as transcutaneous devices to assess nutritional and metabolic status. Noninvasive imaging and novel blood assays are presenting unique opportunities to assess obesity and metabolic dysfunction-associated steatohepatitis.

This workshop aims to provide a comprehensive overview of the current evidence for biomarkers in use as well as those in development. This shall be achieved with a critical review of literature, panel discussions, presentations, open discussions, and question/answer sessions, seeking areas ripe for new clinical, translational, and basic research.